NCT07393958 (ENDOLIRAL) is a NA clinical trial of Food supplement (T1675) in Endometriosis (Diagnosis), sponsored by Arafarma Group, S.A..

Who is sponsoring NCT07393958?

NCT07393958 is sponsored by Arafarma Group, S.A..

What drugs are being tested in NCT07393958?

Interventions in NCT07393958: Food supplement (T1675), Placebo.

What condition does NCT07393958 study?

NCT07393958 studies Endometriosis (Diagnosis).

Is NCT07393958 still recruiting?

NCT07393958 is currently recruiting now. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT07393958: ENDOLIRAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.

Recruiting now NA Last updated 2 March 2026

What this trial tests

NA trial testing Food supplement (T1675) in Endometriosis (Diagnosis) in 60 participants. Currently enrolling.

Timeline

26 February 2026

Primary endpoint
1 August 2026

15 September 2026

Quick facts

Lead sponsor	Arafarma Group, S.A.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	60
Start date	26 February 2026
Primary completion	1 August 2026
Estimated completion	15 September 2026
Sites	1 location across Spain

Drugs / interventions tested

Food supplement (T1675) — full drug profile →
Placebo

Conditions studied

Endometriosis (Diagnosis) — all drugs for Endometriosis (Diagnosis) →

Sponsor

Arafarma Group, S.A. — full company profile →

Who can join

18 and older, female only, with Endometriosis (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines whether the food supplement Doliral can improve quality of life and reduce pelvic pain in women with endometriosis, compared with placebo, over several weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Arafarma Group, S.A. trials

Trials by the same sponsor.

NCT07199556 — Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors. · NA · completed
NCT05718908 — Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement · completed
NCT05525130 — Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Litho · NA · completed
NCT04815499 — Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease. · NA · completed
NCT05109455 — Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07393958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arafarma Group, S.A.
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07393958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing